Transdermal delivery of heparin using pulsed current iontophoresis

Pharmaceutical Research

Volumn 23, Issue 1, 2006, Pages 114-120

  Pacini, Stefania ^a   Punzi, Tiziana ^a   Gulisano, Massimo ^a   Cecchi, Fabiola ^a   Vannucchi, Simonetta ^a   Ruggiero, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiovascular disease; Heparin; Iontophoresis; Rat skin; Transdermal delivery

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RADIOACTIVE MATERIAL; SULFUR 35;

ANIMAL EXPERIMENT; ARTICLE; DERMIS; DRUG DELIVERY SYSTEM; EPIDERMIS; FLUORESCENCE; FOOD AND DRUG ADMINISTRATION; FRACTIONATION; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTICOAGULANTS; DRUG DELIVERY SYSTEMS; FACTOR XA; HEPARIN; IONTOPHORESIS; MALE; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; RATS; RATS, WISTAR; SKIN ABSORPTION; SULFUR RADIOISOTOPES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 32244434635     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-8923-z     Document Type: Article

References (25)

1. R. Hold W. Klein 2003 The rule of low molecular weight heparins in cardiovascular medicine Clin. Pharmacol. Ther. 28 371 378
2. J. J. Ferguson 2002 Defining the scope of evidence-based practise for low molecular weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction Clin. Cardiol. 25 16 22
3. 2+-dependente fashion and modulate its catalytic activity Biochemistry 42 13091 13098
4. F. Y. Avci N. A. Karst R. J. Linhardt 2003 Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties Curr. Pharm. Des. 9 2323 2335
5. H. Zhu K. D. Peck D. J. Miller M. R. Liddell G. Yan W. I. Higuchi S. K. Li 2003 Investigation of properties of human epidermal membrane under constant conductance alternating current iontophoresis J. Control. Release 82 31 46
6. S. Mitragotri J. Kost 2001 Transdermal delivery of heparin and low-molecular heparin using low-frequency ultrasound Pharm. Res. 18 1151 1156
7. G. Pineo R. Hull V. Marder 2004 Oral delivery of heparin: SNAC and related formulations Best Pract. Res. Clin. Haematol. 17 153 160
8. M. R. Prausnitz E. R. Edelman J. A. Gimm R. Langer J. C. Weaver 1995 Transdermal delivery of heparin by skin electroporation Biotechnology (N.Y.) 13 1205 1209
9. R. Vandbever M. R. Prausnitz V. Preat 1997 Macromolecules as novel transdermal transport enhancers for skin electroporation Pharm. Res. 14 638 644
10. S. Cavari G. Fiorelli S. Vannucchi 1994 Binding and growth-inhibitory effect of heparin and oligo-heparin (2 kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover Br. J. Pharmacol. 113 254 260
11. Y. Morimoto M. Mutoh H. Ueda L. Fang K. Hirayama M. Atobe D. Kobayashi 2005 Elucidation of the transport pathwayin hairless rat skin enhanced by low-frequency sonophoresis based on the solute-water transport relationship and confocal microscopy J. Control. Release 103 587 597
12. T. A. Morris A. Jacobson J. J. Marsh J. R. Lane 2005 Pharmacokinetics of UH and LMWH are similar with respect to antithrombotin activity Thromb. Res. 115 45 51
13. E. M. Van Cott M. Laposata 2001 Coagulation D. S. Jacobs W. R. DeMott D. K. Oxley Laboratory Test Handbook 5 Hudson OH 327 358
14. W. W. Ting C. D. Vest R. D. Sontheimer 2004 Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum Pharmacol. Ther. 43 538 547
15. Y. Yamamoto 1994 Measurement and analysis of skin electrical impedance Acta Derm Venereol., Suppl. (Stockh.) 185 34 38
16. R. Edelberg 1977 Relation of electrical properties of skin to structure and physiologic state J. Invest. Dermatol. 69 324 327
17. T. Ngawhirunpat T. Hatanaka K. Katayama H. Yoshikawa J. Kawakami I. Adachi 2002 Changes in electrophysiological properties of rat skin with age Biol. Pharm. Bull. 25 1192 1196
18. M. Kanebako T. Inagi K. Takayama 2002 Evaluation of skin barrier function using direct current II: effects of duty cycle, waveform, frequency and mode Biol. Pharm. Bull. 25 1623 1628
19. T. Chen R. Langer J. C. Weaver 1998 Skin electroporation causes molecular transport across the stratum corneum through localized transport regions J. Investig. Dermatol. Symp. Proc. 3 159 165
20. V. Regnier V. Preat 1998 Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation Pharm. Res. 15 1596 1602
21. P. W. Majerus D. M. Tollefsen 2001 Anticoagulant, thrombolytic, and antiplatelet drugs Goodman & Gilman's The Pharmacological Basis of Therapeutics 10 McGraw-Hill New York
22. D. B. Bommannan J. Tamada L. Leung R. O. Potts 1994 Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro Pharm. Res. 11 1809 1814
23. A. Dunn D. Bioh M. Beran M. Capasso A. Siu 2004 Effect of intravenous heparin administration on duration of hospitalization Mayo Clin. Proc. 79 159 163
24. S. M. Jafri 2004 Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy Am. Heart J. 147 3 15
25. G. E. Bozovich E. P. Gurfinkel E. M. Antman C. H. [tmp] McCabe B. Mautner 2000 Superiority of enoxaparin versus unfractionate heparin for unstable angina/non-Q-wave myocardia infarction regardless of activated partial thromboplastin time Am. Heart J. 140 637 642